Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 4;10(8):e0134986.
doi: 10.1371/journal.pone.0134986. eCollection 2015.

Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation

Jie Wang  1 , Wenwen Zhang  2 , Chunxiao Yu  2 , Xu Zhang  2 , Haiqing Zhang  2 , Qingbo Guan  2 , Jiajun Zhao  2 , Jin Xu  2
Affiliations

Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation

Jie Wang et al. PLoS One. .

Abstract

Objective: The objectives of this study were to observe the changes in follicle-stimulating hormone (FSH) and bone mineral density (BMD) in postmenopausal women, to research the relationship between FSH and postmenopausal osteoporosis, and to observe the effects of FSH on osteoclast differentiation in RAW264.7 cells.

Methods: We analyzed 248 postmenopausal women with normal bone metabolism. A radioimmunoassay (RIA) was used to detect serum FSH, luteinizing hormone (LH), and estradiol (E2). Dual-energy X-ray absorptiometry was used to measure forearm BMD. Then, we analyzed the age-related changes in serum FSH, LH and E2. Additionally, FSH serum concentrations were compared between a group of postmenopausal women with osteoporosis and a control group. Osteoclasts were induced from RAW264.7 cells in vitro by receptor activator of nuclear factor kappa B ligand (RANKL), and these cells were treated with 0, 5, 10, and 20 ng/ml FSH. After the osteoclasts matured, tartrate-resistant acid phosphatase (TRAP) staining was used to identify osteoclasts, and the mRNA expression levels of genes involved in osteoclastic phenotypes and function, such as receptor activator of NF-κB (Rank), Trap, matrix metalloproteinase-9 (Mmp-9) and Cathepsin K, were detected in different groups using real-time PCR (polymerase chain reaction).

Results: 1. FSH serum concentrations in postmenopausal women with osteoporosis increased notably compared with the control group. 2. RANKL induced RAW264.7 cell differentiation into mature osteoclasts in vitro. 3. FSH increased mRNA expression of genes involved in osteoclastic phenotypes and function, such as Rank, Trap, Mmp-9 and Cathepsin K, in a dose-dependent manner.

Conclusions: The circulating concentration of FSH may play an important role in the acceleration of bone loss in postmenopausal women. FSH increases osteoclastogenesis in vitro.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Osteoclast differentiation of RAW264.7 cells induced by RANKL.
RAW264.7 cells were induced to differentiate into osteoclasts as described in the Materials and Methods section, for 1, 4 and 7 days. (A, B, and C) Morphological changes in the cells were observed under a light microscope (original magnification 100x). (D) Representative images of TRAP staining (original magnification 100x). Bars: 50 μm.
Fig 2
Fig 2. mRNA expression of genes involved in osteoclast phenotypes and function.
The mRNA expression levels of Rank, Trap, Mmp-9 and Cathepsin K were significantly upregulated when the RAW264.7 cells were induced to osteoclasts (*P < 0.05 compared with control).
Fig 3
Fig 3. FSH increased Rank, Trap, Mmp-9 and Cathepsin K mRNA expression in osteoclasts.
(*P < 0.05 compared with the control group).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Seibel MJ, Dunstan CR, Zhou H, Allan CM, Handelsman DJ (2006) Sex steroids, not FSH, influence bone mass. Cell 127: 1079; author reply 1080–1071. - PubMed
    1. Imai Y (2014) [Bone metabolism by sex hormones and gonadotropins]. Clin Calcium 24: 815–819. doi: CliCa1406815819 - PubMed
    1. Sowers MR, Zheng H, Greendale GA, Neer RM, Cauley JA, et al. (2013) Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab 98: 2854–2863. 10.1210/jc.2012-4113 - DOI - PMC - PubMed
    1. Sowers MR, Jannausch M, McConnell D, Little R, Greendale GA, et al. (2006) Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 91: 1261–1267. - PubMed
    1. Xu ZR, Wang AH, Wu XP, Zhang H, Sheng ZF, et al. (2009) Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. Clin Chim Acta 400: 8–13. 10.1016/j.cca.2008.09.027 - DOI - PubMed

Publication types

MeSH terms

Grants and funding

This work was supported by the National Natural Science Foundation (81370892, http://www.nsfc.gov.cn/), the Technology Development Plan Project of Shandong Province (2012GSF11823, http://www.sdstc.gov.cn/) and the Shandong Province Young and Middle-Aged Scientists Research Awards Fund (2007BS03004, http://www.sdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

LinkOut - more resources